RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Neuroblastoma-Targeting π-Conjugated COP Nanostructure with Multiple Enzyme-Mimetic Actions for Sonochemodynamic Immunotherapies.
Neuroblastoma-Targeting π-Conjugated COP Nanostructure with Multiple Enzyme-Mimetic Actions for Sonochemodynamic Immunotherapies.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
声动力疗法(SDT)已成为神经母细胞瘤治疗的一种有前景的策略,其利用超声在肿瘤部位诱导活性氧(ROS)的产生,从而增强免疫治疗的疗效。
然而,SDT的一个主要挑战是ROS生成的效率,尤其是在肿瘤微环境缺氧的背景下。在此,受天然过氧化物酶的启发,设计了一种基于酰亚胺连接金属酞菁的共轭有机聚合物(COP)(COP TPcFe),其具有明确的π共轭纳米结构和过氧化物酶模拟的原子Fe-N位点,用于针对神经母细胞瘤的声化学动力免疫治疗。
本研究表明,COP TPcFe能够利用局部H2O2和超声效应高效产生强效ROS(•OH和•O2-),从而实现高效且协同的杀肿瘤活性。
值得注意的是,高度π共轭结构赋予COP TPcFe优异的电子传输能力,能够快速催化H2O2生成O2,从而缓解肿瘤内的缺氧条件。
此外,通过用神经母细胞瘤细胞膜包裹COP TPcFe,本研究实现了对肿瘤细胞和组织的同源靶向,导致在肿瘤细胞内的高效蓄积、线粒体破坏和凋亡。
此外,所提出的声化学动力免疫治疗有效激活NK 细胞并逆转免疫抑制性肿瘤微环境,从而缓解缺氧并显著增强神经母细胞瘤治疗的治疗疗效。
Sonodynamic therapy (SDT) has emerged as a promising strategy for neuroblastoma treatment, leveraging ultrasound to induce the production of reactive oxygen species (ROS) at tumor sites, thereby enhancing the efficacy of immunotherapy.
However, a major challenge in SDT is the efficiency of ROS generation, particularly in the context of hypoxia within the tumor microenvironment.
Herein, inspired by the natural peroxidase, an imide-linked metal-phthalocyanine-based conjugated organic polymer (COP) (COP TPcFe ) has been designed with a well-defined π-conjugated nanostructure and peroxidase-mimetic atomic Fe-N sites for sonochemodynamic immunotherapy against neuroblastoma. This work demonstrates that COP TPcFe can efficiently produce potent ROS (•OH and •O 2 - ) by utilizing localized H 2 O 2 and the effects of ultrasound, thereby achieving efficient and synergistic tumoricidal activity.
Notably, the highly π-conjugated structure endows COP TPcFe with excellent electron transport capabilities, enabling rapid catalysis of H 2 O 2 to O 2 , thus alleviating the hypoxic conditions within tumors.
Moreover, by encapsulating COP TPcFe with neuroblastoma cell membranes, this study achieveshomologous targeting of tumor cells and tissues, leading to efficient accumulation within tumor cells, mitochondrial disruption, and apoptosis.
Additionally, the proposed sonochemodynamic immunotherapy effectively activates natural killer cells and reverses the immunosuppressive tumor microenvironment, thereby alleviating hypoxia and significantly enhancing the therapeutic efficacy of neuroblastoma treatment.
MEMBER ACCOUNT
登录成功会直接打开下一页。